Luca Issi
Stock Analyst at RBC Capital
(0.86)
# 4,037
Out of 4,966 analysts
700
Total ratings
39.7%
Success rate
-0.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Luca Issi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics | Maintained: Buy | $35 → $30 | $20.31 | +47.71% | 13 | Sep 9, 2026 | |
| RARE Ultragenyx Pharmaceutical | Downgraded: Hold | $40 → $19 | $14.88 | +27.69% | 21 | Sep 3, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintained: Buy | $100 | $85.11 | +17.50% | 41 | Aug 30, 2026 | |
| MRNA Moderna | Maintained: Hold | $45 → $130 | $140.33 | -7.36% | 40 | Aug 19, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Buy | n/a | $869.20 | - | 3 | Aug 18, 2026 | |
| ARGX argenx SE | Maintained: Buy | $1,025 → $1,100 | $1,007.07 | +9.23% | 13 | Aug 17, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $100 | $74.76 | +33.76% | 5 | Aug 14, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $280 → $290 | $270.09 | +7.37% | 17 | Aug 13, 2026 | |
| CRBU Caribou Biosciences | Maintained: Buy | $10 | $1.54 | +549.35% | 23 | Aug 13, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $9 | $1.86 | +383.87% | 33 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $4.76 | +320.17% | 15 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $62 | $64.63 | -4.07% | 37 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $10 | $13.51 | -25.98% | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $8.76 | +116.89% | 40 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 | $12.74 | +17.74% | 37 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $370 → $400 | $393.17 | +1.74% | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 | $3.03 | +32.01% | 27 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 | $26.83 | -3.09% | 26 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 | $54.78 | -8.73% | 30 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $445 → $350 | $260.10 | +34.56% | 65 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $32 | $33.55 | -4.62% | 8 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $4.91 | +205.50% | 28 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $56.71 | +49.89% | 41 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $45.68 | +42.29% | 44 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $4 | $3.82 | +4.71% | 6 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $0.1605 | +1,146.11% | 21 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $11 | $13.53 | n/a | 17 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $54 | $11.69 | n/a | 13 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $3 | $5.33 | n/a | 7 | Mar 21, 2023 |
Dyne Therapeutics
Sep 9, 2026
Maintained: Buy
Price Target: $35 → $30
Current: $20.31
Upside: +47.71%
Ultragenyx Pharmaceutical
Sep 3, 2026
Downgraded: Hold
Price Target: $40 → $19
Current: $14.88
Upside: +27.69%
Arrowhead Pharmaceuticals
Aug 30, 2026
Maintained: Buy
Price Target: $100
Current: $85.11
Upside: +17.50%
Moderna
Aug 19, 2026
Maintained: Hold
Price Target: $45 → $130
Current: $140.33
Upside: -7.36%
argenx SE
Aug 18, 2026
Maintained: Buy
Price Target: n/a
Current: $869.20
Upside: -
argenx SE
Aug 17, 2026
Maintained: Buy
Price Target: $1,025 → $1,100
Current: $1,007.07
Upside: +9.23%
BridgeBio Pharma
Aug 14, 2026
Maintained: Buy
Price Target: $100
Current: $74.76
Upside: +33.76%
Ascendis Pharma
Aug 13, 2026
Maintained: Buy
Price Target: $280 → $290
Current: $270.09
Upside: +7.37%
Caribou Biosciences
Aug 13, 2026
Maintained: Buy
Price Target: $10
Current: $1.54
Upside: +549.35%
Allogene Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $9
Current: $1.86
Upside: +383.87%
Aug 12, 2026
Maintained: Buy
Price Target: $20
Current: $4.76
Upside: +320.17%
Aug 7, 2026
Maintained: Hold
Price Target: $62
Current: $64.63
Upside: -4.07%
Aug 7, 2026
Maintained: Hold
Price Target: $8 → $10
Current: $13.51
Upside: -25.98%
Aug 6, 2026
Maintained: Buy
Price Target: $19
Current: $8.76
Upside: +116.89%
Aug 6, 2026
Maintained: Hold
Price Target: $15
Current: $12.74
Upside: +17.74%
Aug 5, 2026
Maintained: Buy
Price Target: $370 → $400
Current: $393.17
Upside: +1.74%
Aug 5, 2026
Maintained: Hold
Price Target: $4
Current: $3.03
Upside: +32.01%
Aug 5, 2026
Reiterated: Hold
Price Target: $26
Current: $26.83
Upside: -3.09%
Aug 3, 2026
Maintained: Hold
Price Target: $50
Current: $54.78
Upside: -8.73%
Jul 30, 2026
Rated: Buy
Price Target: $445 → $350
Current: $260.10
Upside: +34.56%
Jul 30, 2026
Maintained: Hold
Price Target: $32
Current: $33.55
Upside: -4.62%
Jul 30, 2026
Maintained: Buy
Price Target: $15
Current: $4.91
Upside: +205.50%
Jul 29, 2026
Reiterated: Buy
Price Target: $85
Current: $56.71
Upside: +49.89%
Jul 29, 2026
Reiterated: Buy
Price Target: $65
Current: $45.68
Upside: +42.29%
Jun 2, 2026
Maintained: Hold
Price Target: $10 → $4
Current: $3.82
Upside: +4.71%
May 14, 2026
Maintained: Hold
Price Target: $2
Current: $0.1605
Upside: +1,146.11%
Nov 13, 2024
Maintained: Buy
Price Target: $9 → $11
Current: $13.53
Upside: n/a
May 11, 2023
Maintained: Hold
Price Target: $3 → $54
Current: $11.69
Upside: n/a
Mar 21, 2023
Maintained: Hold
Price Target: $4 → $3
Current: $5.33
Upside: n/a